4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000814
Chief Financial Officer sold 12,500 shares at $27.97 ($349,591)
- Chief Financial Officer acquired 12,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hyep Ivan · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,500 | $3.79 | $47,373 | 142,355 | D |
| 2026-08-10 | Sale : show line 2 in the form 10b5-1 | −12,500 | $27.97 | $349,591 | 129,855 | D |
| Open-market sales · 12,500 sh · avg $27.97 · $349,591 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −12,500 | 26,336 | D |
Loading xslF345X06/wk-form4_1786565959.xml…